Mount Lucas Management LP trimmed its position in DaVita Inc. (NYSE:DVA - Free Report) by 29.0% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,092 shares of the company's stock after selling 3,718 shares during the quarter. Mount Lucas Management LP's holdings in DaVita were worth $1,391,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DVA. Raymond James Financial Inc. acquired a new stake in shares of DaVita during the 4th quarter worth $3,864,000. Royal London Asset Management Ltd. grew its holdings in shares of DaVita by 6.0% during the 4th quarter. Royal London Asset Management Ltd. now owns 21,926 shares of the company's stock worth $3,279,000 after purchasing an additional 1,242 shares in the last quarter. Sei Investments Co. grew its holdings in shares of DaVita by 212.6% during the 4th quarter. Sei Investments Co. now owns 90,769 shares of the company's stock worth $13,578,000 after purchasing an additional 61,731 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of DaVita during the 4th quarter worth $4,234,000. Finally, Mitsubishi UFJ Trust & Banking Corp grew its holdings in shares of DaVita by 15.3% during the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 128,528 shares of the company's stock worth $19,221,000 after purchasing an additional 17,008 shares in the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research firms have commented on DVA. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. Truist Financial lowered their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research report on Monday, May 19th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $164.50.
Read Our Latest Research Report on DVA
DaVita Stock Performance
NYSE:DVA opened at $146.09 on Wednesday. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.20 and a current ratio of 1.25. DaVita Inc. has a 52-week low of $131.76 and a 52-week high of $179.60. The firm has a market cap of $11.03 billion, a price-to-earnings ratio of 14.48, a PEG ratio of 0.96 and a beta of 1.11. The business's fifty day moving average is $140.11 and its 200 day moving average is $148.56.
DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.75 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The business had revenue of $3.22 billion during the quarter, compared to analysts' expectations of $3.22 billion. During the same period in the previous year, the business earned $2.26 earnings per share. The firm's revenue was up 5.0% on a year-over-year basis. Research analysts predict that DaVita Inc. will post 10.76 EPS for the current year.
DaVita Company Profile
(
Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
